Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-01-06 @ 4:12 AM
Study NCT ID:
NCT05128734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2021-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Sponsor:
AHS Cancer Control Alberta
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
None
Study First Post Date:
2021-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED